|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.24 USD | -3.10% |
|
-3.89% | +29.43% |
| 07-07 | RBC Capital Adjusts Cytokinetics Price Target to $117 From $119, Maintains Outperform Rating | MT |
| 07-02 | Cytokinetics Insider Sold Shares Worth $1,287,000, According to a Recent SEC Filing | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 87.26 | 87.26 | 86.49 |
| Spread/Res. | -5.75% | -5.75% | -4.91% |
| Spread/Supp. | +7.80% | +13.76% | +55.14% |
| Support | 76.29 | 72.29 | 53.01 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CYTK Stock
- Charts Cytokinetics, Incorporated
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition